Oligonucleotide Primer Design for Bias-Free mRNA Amplification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for reverse transcription of mRNA into DNA and subsequent amplification suffer from high bias and inefficiency, necessitating improved primer compositions and processes to enhance these processes.

Innovation Solution

The use of specific oligonucleotide primers with defined sequences (SEQ ID NO: 1, 2, and 3) for hybridization and extension by reverse transcriptase, followed by in vitro transcription and amplification to generate high-quality cDNA and RNA, which can be used to stimulate immune responses in dendritic cells.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If standard reverse transcription methods are used with conventional primers, then the process is simple to perform, but the method suffers from high bias and inefficiency during reverse transcription and in vitro transcription

Engineering Contradiction:
Improvereverse transcription efficiencyVSAvoidprimer composition complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The primer is divided into distinct functional segments: a 5′ transcriptionally active promoter region (e.g., T7 promoter) and a 3′ reverse transcription primer region (e.g., poly(T) sequence). This segmentation allows each region to perform its specific function optimally—the promoter region enables efficient in vitro transcription while the poly(T) region facilitates reverse transcription of mRNA—thereby resolving the contradiction between improving transcription efficiency and maintaining simple primer composition.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The primer is designed to perform multiple functions: it serves as both a reverse transcription primer (via the poly(T) region that hybridizes to the poly(A) tail of mRNA) and as a promoter for in vitro transcription (via the 5′ promoter region). This multi-functionality eliminates the need for separate primers for reverse transcription and transcription initiation, improving overall process efficiency without significantly increasing complexity.

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Ease of operation

If poly(T) primers are used to capture 3′ sequence information from mRNA, then the process is simple, but the method exhibits high bias during reverse transcription

Engineering Contradiction:
ImprovemRNA capture simplicityVSAvoidreverse transcription accuracy
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The primer design incorporates specific parameter optimizations: the poly(T) region is configured with a defined length (e.g., 15-20 T residues) and is positioned at the 3′ end of the primer, while the 5′ promoter region is positioned to allow proper hybridization and extension. These parameter changes reduce reverse transcription bias by ensuring optimal binding conditions and minimizing non-specific interactions, thereby improving reverse transcription accuracy while maintaining operational simplicity.

Inventive Principle:
Principle #35Parameter changes

3Productivity

If in vitro transcription is performed to generate large quantities of target mRNA, then the产量 is increased, but the in vitro transcription efficiency is low

Engineering Contradiction:
ImprovemRNA production quantityVSAvoidin vitro transcription efficiency
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The promoter region (e.g., T7 promoter sequence) is pre-incorporated into the primer during the reverse transcription step. This preliminary action ensures that when the cDNA is used as a template for in vitro transcription, the RNA polymerase can immediately recognize and bind to the pre-positioned promoter, eliminating the need for separate promoter addition steps and significantly improving transcription efficiency and productivity.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The primer is constructed as a composite molecule combining DNA (promoter region) and RNA-hybridizing sequences (poly(T) region). This composite structure allows the primer to function in both reverse transcription (via RNA-DNA hybridization) and in vitro transcription (via promoter recognition), thereby improving transcription efficiency while maintaining the ability to generate large quantities of mRNA.

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach reduces bias and increases the efficiency of reverse transcription and amplification, enabling the generation of high-quality RNA for immune stimulation, as demonstrated by enhanced IFNγ production and antigen-specific CD8+CD25+ T cell activation.

Implementation Method 1

RNA, which generally exists transiently in vivo, can be reverse transcribed by a RNA dependent DNA polymerase (reverse transcriptase) in order to generate a DNA copy

Methodology Applied
Scientific EffectReverse transcription:

Implementation Method 2

DNA can be replicated and amplified in vitro by the polymerase chain reaction, in which primers are hybridized to opposite ends, and opposite strands of a target nucleic acids, and the primers are extended by a DNA dependent DNA polymerase

Methodology Applied
Scientific EffectPolymerase chain reaction:

Implementation Method 3

The primers used in cDNA synthesis and amplification may include a promoter so that the cDNA can be transcribed using a process of in vitro transcription to generate large quantities of target mRNA

Methodology Applied
Scientific EffectIn vitro transcription:

Data Source

PatentUS20240026436A1Methods and compositions for the amplification of mRNA
Publication Date: 2024.01.25 BAYLOR COLLEGE OF MEDICINE
  • US20240026436A1 patent drawing
  • US20240026436A1 patent drawing
  • US20240026436A1 patent drawing

AI summary

Provided herein are compositions and methods for the synthesis, amplification, and in vitro transcription of full-length cDNA, or cDNA fragments. Methods are provided for reverse transcription of RNA and amplification for in vitro transcription. Further provided are method for loading of dendritic cells with the RNA and homologous lysate for immune stimulation.